Magnetar Financial LLC Iovance Biotherapeutics, Inc. Transaction History

Magnetar Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $640,784 - $1.17 Million	82,363 New	82,363 $660,000
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $258,144 - $473,520	-9,004 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $252,472 - $452,541	9,004 New	9,004 $418,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.